Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
BlossomHill Therapeutics, Inc. (BLSM) is the issuer named in a Schedule 13G in which reporting persons Jingrong Jean Cui and Yishan Li each report beneficial ownership of 3,973,138 common shares, or 12.5% of the class. Both list shared voting and dispositive power over the same reported amount. The amount comprises shares held directly by each spouse and shares held by The Li and Cui Family Trust and RongShan, LLC; each person disclaims beneficial ownership of the trust and LLC shares, and of shares held directly by the other spouse, except to the extent of his or her pecuniary interest. The percentage is based on 31,784,909 shares outstanding as of November 10, 2026. The reported amounts exclude options held by the spouses that are not exercisable within 60 days of September 30, 2026.
Key Figures
Reported beneficial ownership:3,973,138 sharesClass ownership:12.5%Common shares outstanding:31,784,909 shares+4 more
7 metrics
Reported beneficial ownership3,973,138 sharesEach reporting person reports this same amount.
Class ownership12.5%Reported by each person.
Common shares outstanding31,784,909 sharesAs of November 10, 2026.
Shares held by The Li and Cui Family Trust1,714,117 sharesIncluded in the reported beneficial ownership.
Shares held by RongShan, LLC124,779 sharesIncluded in the reported beneficial ownership.
Shares held directly by Jingrong Jean Cui1,067,121 sharesIncluded in the reported beneficial ownership.
Shares held directly by Yishan Li1,067,121 sharesIncluded in the reported beneficial ownership.
"Amount beneficially owned: 3,973,138 shares of common stock"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
Shared voting powerregulatory
"Shared voting power: 3,973,138"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
Shared dispositive powerregulatory
"Shared dispositive power: 3,973,138"
pecuniary interestregulatory
"except to the extent of his or her pecuniary interest therein"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many BLSM shares do Jingrong Jean Cui and Yishan Li report?
Each reports 3,973,138 shares of common stock, representing 12.5% of the class. The percentage is based on 31,784,909 shares outstanding as of November 10, 2026.
What shares make up Cui and Li's reported BLSM ownership?
The amount comprises 1,067,121 shares held directly by each spouse, 1,714,117 held by The Li and Cui Family Trust, and 124,779 held by RongShan, LLC. The spouses serve as trustees of the trust, and Yishan Li is RongShan's manager. Each disclaims beneficial ownership of certain shares held by the other or by those entities, except to the extent of pecuniary interest.
Do Jingrong Jean Cui and Yishan Li say they are a group?
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
BlossomHill Therapeutics, Inc.
(Name of Issuer)
Common Stock, $0.0001 par value per share
(Title of Class of Securities)
095130100
(CUSIP Number)
09/30/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
schemaVersion:
SCHEDULE 13G
CUSIP Number(s):
095130100
1
Names of Reporting Persons
Jingrong Jean Cui
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
3,973,138.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
3,973,138.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
3,973,138.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
12.5 %
12
Type of Reporting Person (See Instructions)
IN
Comment for Type of Reporting Person: (1) Consists of (a) 1,067,121 shares of common stock held directly by the Reporting Person, (b) 1,067,121 shares of common stock held directly by Yishan Li, the Reporting Person's spouse, (c) 1,714,117 shares of common stock held by The Li and Cui Family Trust (the "Trust"), and (d) 124,779 shares of common stock held by RongShan, LLC ("RongShan"). The Reporting Person and her spouse serve as trustees of the Trust and share voting and dispositive power over the shares held by the Trust. The Reporting Person's spouse is the manager of RongShan. The Reporting Person and her spouse may each be deemed to have shared voting and dispositive power over the shares held by the other. Excludes 676,205 shares of common stock underlying stock options held by the Reporting Person and 112,701 shares of common stock underlying stock options held by her spouse, none of which are exercisable within 60 days of September 30, 2026.
(2) Based on 31,784,909 shares of common stock outstanding as of November 10, 2026, as reported in the Issuer's Quarterly Report on Form 10-Q for the quarter ended September 30, 2026, filed with the Securities and Exchange Commission on November 12, 2026.
SCHEDULE 13G
CUSIP Number(s):
095130100
1
Names of Reporting Persons
Yishan Li
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
3,973,138.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
3,973,138.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
3,973,138.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
12.5 %
12
Type of Reporting Person (See Instructions)
IN
Comment for Type of Reporting Person: (1) Consists of (a) 1,067,121 shares of common stock held directly by the Reporting Person, (b) 1,067,121 shares of common stock held directly by Jingrong Jean Cui, the Reporting Person's spouse, (c) 1,714,117 shares of common stock held by The Li and Cui Family Trust (the "Trust"), and (d) 124,779 shares of common stock held by RongShan, LLC ("RongShan"). The Reporting Person and his spouse serve as trustees of the Trust and share voting and dispositive power over the shares held by the Trust. The Reporting Person is the manager of RongShan and may be deemed to have voting and dispositive power over the shares held by RongShan. The Reporting Person and his spouse may each be deemed to have shared voting and dispositive power over the shares held by the other. Excludes 112,701 shares of common stock underlying stock options held by the Reporting Person and 676,205 shares of common stock underlying stock options held by his spouse, none of which are exercisable within 60 days of September 30, 2026.
(2) Based on 31,784,909 shares of common stock outstanding as of November 10, 2026, as reported in the Issuer's Quarterly Report on Form 10-Q for the quarter ended September 30, 2026, filed with the Securities and Exchange Commission on November 12, 2026.
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
BlossomHill Therapeutics, Inc.
(b)
Address of issuer's principal executive offices:
10255 Science Center Drive, Suite 200, San Diego, CA 92121
Item 2.
(a)
Name of person filing:
(i) Jingrong Jean Cui and (ii) Yishan Li (together, the "Reporting Persons")
The Reporting Persons expressly disclaim status as a "group" for purposes of this Schedule 13G.
(b)
Address or principal business office or, if none, residence:
c/o BlossomHill Therapeutics, Inc., 10255 Science Center Drive, Suite 200, San Diego, CA 92121
(c)
Citizenship:
Jingrong Jean Cui and Yishan Li are United States citizens.
(d)
Title of class of securities:
Common Stock, $0.0001 par value per share
(e)
CUSIP Number(s):
095130100
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
3,973,138 shares of common stock, consisting of (i) 1,714,117 shares held by The Li and Cui Family Trust (the "Trust"), (ii) 124,779 shares held by RongShan, LLC ("RongShan"), (iii) 1,067,121 shares held directly by Jingrong Jean Cui, and (iv) 1,067,121 shares held directly by Yishan Li. The Reporting Persons are spouses and serve as trustees of the Trust, with voting and dispositive power over the shares held by the Trust. Yishan Li is the manager of RongShan and may be deemed to have voting and dispositive power over the shares held by RongShan. Each Reporting Person may be deemed to have shared voting and dispositive power over the shares held by the other. Each Reporting Person disclaims beneficial ownership of the shares held by the Trust and RongShan, and of the shares held directly by the other Reporting Person, except to the extent of his or her pecuniary interest therein, and this statement shall not be deemed an admission that either Reporting Person is the beneficial owner of such shares for purposes of Section 13(d) or 13(g) of the Securities Exchange Act of 1934, as amended, or for any other purpose.
(b)
Percent of class:
12.5%. See footnote (2) to the cover pages.
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
0
(ii) Shared power to vote or to direct the vote:
3,973,138
(iii) Sole power to dispose or to direct the disposition of:
0
(iv) Shared power to dispose or to direct the disposition of:
3,973,138
Item 5.
Ownership of 5 Percent or Less of a Class.
Not Applicable
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
Not Applicable
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not Applicable
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
Not Applicable
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.